J. L. Bainbridge & Co., Inc. Bristol Myers Squibb CO Transaction History

J. L. Bainbridge & Co., Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	SELL	$68.48 - $81.09 $37,732 - $44,680	-551 Reduced 0.18%	303,693 $0
Q3 2022 Nov 02, 2022	SELL	$0.13 - $76.84 $738 - $436,604	-5,682 Reduced 1.83%	304,244 $21.6 Million
Q2 2022 Aug 04, 2022	SELL	$72.62 - $79.98 $19.9 Million - $22 Million	-274,594 Reduced 46.98%	309,926 $23.9 Million
Q1 2022 May 06, 2022	SELL	$61.48 - $73.72 $690,051 - $827,433	-11,224 Reduced 1.88%	584,520 $42.7 Million
Q4 2021 Feb 07, 2022	SELL	$53.63 - $62.52 $1.04 Million - $1.22 Million	-19,443 Reduced 3.16%	595,744 $37.1 Million
Q3 2021 Oct 28, 2021	SELL	$59.17 - $69.31 $821,220 - $961,953	-13,879 Reduced 2.21%	615,187 $36.4 Million
Q2 2021 Aug 02, 2021	BUY	$61.91 - $67.42 $295,867 - $322,200	4,779 Added 0.77%	629,066 $42 Million
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $244,896 - $275,435	4,127 Added 0.67%	624,287 $39.4 Million
Q4 2020 Feb 03, 2021	SELL	$57.74 - $65.43 $679,888 - $770,438	-11,775 Reduced 1.86%	620,160 $38.5 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $657,573 - $728,678	-11,450 Reduced 1.78%	631,935 $38.1 Million
Q2 2020 Aug 11, 2020	BUY	$54.82 - $64.09 $2.01 Million - $2.35 Million	36,596 Added 6.03%	643,385 $37.8 Million
Q1 2020 May 12, 2020	BUY	$46.4 - $67.43 $194,230 - $282,261	4,186 Added 0.69%	606,789 $33.8 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $29.7 Million - $38.7 Million	602,603 New	602,603 $38.7 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of J. L. Bainbridge & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on J. L. Bainbridge & Co., Inc. with notifications on news.